Median nerve stimulation induces analgesia via orexin-initiated endocannabinoid disinhibition in the periaqueductal gray
- aGraduate Institute of Acupuncture Science, China Medical University, Taichung, Taiwan 40402;
- bChinese Medicine Research Center, China Medical University, Taichung, Taiwan 40402;
- cDepartment of Photonics and Communication Engineering, Asia University, Taichung, Taiwan 41354;
- dDepartment of Pharmacology, College of Medicine, National Taiwan University, Taipei, Taiwan 10051;
- eGraduate Institute of Brain and Mind Sciences, College of Medicine, National Taiwan University, Taipei, Taiwan 10051;
- fFaculty of Pharmaceutical Sciences, UCSI University, 56000 Kuala Lumpur, Malaysia;
- gGraduate Institute of Biomedical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan 110;
- hDepartment of Physiology, College of Medicine, Taipei Medical University, Taipei, Taiwan 110;
- iInstitute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Zhunan, Miaoli County, Taiwan 35053;
- jInstitute for Molecular Psychiatry, University of Bonn, 53113 Bonn, Germany;
- kGill Center for Biomolecular Research, Indiana University, Bloomington, IN 47405;
- lDepartment of Psychological and Brain Sciences, Indiana University, Bloomington, IN 47405
See allHide authors and affiliations
Edited by Tomas Hökfelt, Karolinska Institutet, Stockholm, Sweden, and approved September 18, 2018 (received for review May 10, 2018)

Significance
Pain remains an unmet medical need due to the ineffectiveness or significant side effects of current pain therapies. Peripheral neurostimulation has been used to relieve pain for decades, but its mechanism(s) remain unsettled. Here, we established an animal model of median nerve stimulation by electrically stimulating the PC6 (Neiguan) acupoint of mice (MNS-PC6). We found MNS-PC6 can release an endogenous neuropeptide (orexin) from the hypothalamus to inhibit pain responses in mice through an endocannabinoid (an endogenous lipid functioning like chemicals from cannabis) that reduces the inhibitory (GABAergic) control in a midbrain pain-control region (the periaqueductal gray). Importantly, MNS-PC6–induced pain relief is endogenous opioid independent. Thus, MNS-PC6 may provide an alternative strategy for pain management in opioid-tolerant patients.
Abstract
Adequate pain management remains an unmet medical need. We previously revealed an opioid-independent analgesic mechanism mediated by orexin 1 receptor (OX1R)-initiated 2-arachidonoylglycerol (2-AG) signaling in the ventrolateral periaqueductal gray (vlPAG). Here, we found that low-frequency median nerve stimulation (MNS) through acupuncture needles at the PC6 (Neiguan) acupoint (MNS-PC6) induced an antinociceptive effect that engaged this mechanism. In mice, MNS-PC6 reduced acute thermal nociceptive responses and neuropathy-induced mechanical allodynia, increased the number of c-Fos–immunoreactive hypothalamic orexin neurons, and led to higher orexin A and lower GABA levels in the vlPAG. Such responses were not seen in mice with PC6 needle insertion only or electrical stimulation of the lateral deltoid, a nonmedian nerve-innervated location. Directly stimulating the surgically exposed median nerve also increased vlPAG orexin A levels. MNS-PC6–induced antinociception (MNS-PC6-IA) was prevented by proximal block of the median nerve with lidocaine as well as by systemic or intravlPAG injection of an antagonist of OX1Rs or cannabinoid 1 receptors (CB1Rs) but not by opioid receptor antagonists. Systemic blockade of OX1Rs or CB1Rs also restored vlPAG GABA levels after MNS-PC6. A cannabinoid (2-AG)-dependent mechanism was also implicated by the observations that MNS-PC6-IA was prevented by intravlPAG inhibition of 2-AG synthesis and was attenuated in Cnr1−/− mice. These findings suggest that PC6-targeting low-frequency MNS activates hypothalamic orexin neurons, releasing orexins to induce analgesia through a CB1R-dependent cascade mediated by OX1R-initiated 2-AG retrograde disinhibition in the vlPAG. The opioid-independent characteristic of MNS-PC6–induced analgesia may provide a strategy for pain management in opioid-tolerant patients.
Footnotes
↵1H.-J.L. and M.T.L. contributed equally to this work.
- ↵2To whom correspondence should be addressed. Email: lcchiou{at}ntu.edu.tw.
Author contributions: Y.-H.C., M.T.L., A.Z., K.M., and L.-C.C. designed research; H.-J.L., M.T.L., Y.-T.W., and Y.-H.L. performed research; M.-S.H. and A.Z. contributed new reagents/analytic tools; Y.-H.C., H.-J.L., M.T.L., L.-L.H., K.M., and L.-C.C. analyzed data; and Y.-H.C., M.T.L., L.-L.H., A.Z., K.M., and L.-C.C. wrote the paper.
The authors declare no conflict of interest.
This article is a PNAS Direct Submission.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1807991115/-/DCSupplemental.
Published under the PNAS license.
Citation Manager Formats
Article Classifications
- Biological Sciences
- Neuroscience